Citations

Showing 10 of 108162 citations.

Vestibular Schwannomas
Carlson, Matthew L. , Link, Michael J.

Mayo Clinic

New England Journal of Medicine | April 7, 2021 | Volume: 384 | Issue: 14 | Pages: 1335-1348

10.1056/nejmra2020394 | PMID 33826821 Get It

Effectiveness of a Weight Loss Program Using Digital Health in Adolescents and Preadolescents
Lei, Sha , Medina‐Inojosa, José R. , Kumar, Seema, Lee, Alexander T., Lerman, Lilach O. , Senecal, Conor , Lin, Weihua, Inojosa, Jose R Medina, Senecal, Conor G, Medina-Inojosa, José R , Scott, Christopher G. , Lerman, Amir , Zhang, Xiaoyong , Cohen, Pinchas , López-Jiménez, Francisco

Mayo Clinic

Childhood Obesity | April 7, 2021 | Volume: 17 | Issue: 5 | Pages: 311-321

10.1089/chi.2020.0317 | PMID 33826417 Get It

Objective: To identify an efficacious intervention on treating adolescents with overweight and obesity, this might result in health benefits. Methods: Adolescents with overweight or obesity aged 10–17 years with BMI percentile ≥85th were included in this historical observational analysis. Subjects used an entirely remote weight loss program combining mobile applications, frequent self-weighing, and calorie restriction with meal replacement. Body weight changes were evaluated at 42, 60, 90, and 120 days using different metrics including absolute body weight, BMI, and BMI z-score. Chi-square or Fisher exact tests (categorical variables) and Student's t -test (continuous variables) were used to compare subjects. Results: In total, 2,825 participants, mean age 14.4 ± 2.2 years, (54.8% girls), were included from October 27, 2016, to December 31, 2017, in mainland China; 1355 (48.0%) had a baseline BMI percentile ≥97th. Mean BMI and BMI z-score were 29.20 ± 4.44 kg/m 2 and 1.89 ± 0.42, respectively. At day 120, mean reduction in body weight, BMI, and BMI z-score was 8.6 ± 0.63 kg, 3.13 ± 0.21 kg/m 2 , and 0.42 ± 0.03; 71.4% had lost ≥5% body weight, 69.4% of boys and 73.2% of girls, respectively. Compared with boys, girls achieved greater reduction on BMI z-score at all intervals ( p < 0.004 for all comparisons). Higher BMI percentile at baseline and increased frequency of use of the mobile application were directly associated with more significant weight loss. Conclusions: An entirely remote digital weight loss program is effective in facilitating weight loss in adolescents with overweight or obesity in the short term and mid term.
Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)
Broman, Kristy K. , Dossett, Lesly A. , Кириченко, Д. А. , Carr, Michael J. , Sharma, Avinash , Bartlett, Edmund K. , Nijhuis, Amanda A. G. , Kottschade, Lisa A. , Downs, Jennifer , Akkooi, Alexander C. J. van , Ollila, David W. , Frank, Jill S. , Karakousis, Giorgos C. , Nobes, Jenny , Vetto, John T. , Han, Dale , Farma, Jeffrey M. , Deneve, Jeremiah L. , Fleming, Martin D. , Bagge, Roger Olofsson , Lee, Ann Y. , Berman, Russell S. , Chai, Harvey , Kroon, Hidde M. , Teras, Jüri, Teras, Roland M., Hui, Jane Yuet Ching , Been, Lukas B. , Kruijff, Schelto , Naqvi, Syeda Mahrukh Hussnain , Sondak, Vernon K. , Broman, Kristy Kummerow , Kirichenko, Dennis , Bartlett, Edmund K , Hieken, Tina J , Kottschade, Lisa, Song, Yun , Karakousis, Giorgos , Lowe, Michael C , Hui, Jane Yuet Ching , Olofsson Bagge, Roger , Hughes, Tasha M. , Sun, James X. , Thompson, John F. , Hieken, Tina J. , Gyorki, David E. , Stahlie, Emma H. A. , Moncrieff, Marc D. , Perez, Matthew C , Mattsson, Jan , Farrow, Norma E. , Beasley, Georgia M. , Kim, Youngchul , Sarnaik, Amod A. , Zager, Jonathan S.

Mayo Clinic

Cancer | April 7, 2021 | Volume: 127 | Issue: 13 | Pages: 2251-2261

10.1002/cncr.33483 | PMID 33826754 Get It

BackgroundFor patients with sentinel lymph node (SLN)‐positive cutaneous melanoma, the Second Multicenter Selective Lymphadenectomy trial demonstrated equivalent disease‐specific survival (DSS) with active surveillance using nodal ultrasound versus completion lymph node dissection (CLND). Adoption and outcomes of active surveillance in clinical practice and in adjuvant therapy recipients are unknown.MethodsIn a retrospective cohort of SLN‐positive adults treated at 21 institutions in Australia, Europe, and the United States from June 2017 to November 2019, the authors evaluated the impact of active surveillance and adjuvant therapy on all‐site recurrence‐free survival (RFS), isolated nodal RFS, distant metastasis‐free survival (DMFS), and DSS using Kaplan‐Meier curves and Cox proportional hazard models.ResultsAmong 6347 SLN biopsies, 1154 (18%) were positive and had initial negative distant staging. In total, 965 patients (84%) received active surveillance, 189 (16%) underwent CLND. Four hundred thirty‐nine patients received adjuvant therapy (surveillance, 38%; CLND, 39%), with the majority (83%) receiving anti–PD‐1 immunotherapy. After a median follow‐up of 11 months, 220 patients developed recurrent disease (surveillance, 19%; CLND, 22%), and 24 died of melanoma (surveillance, 2%; CLND, 4%). Sixty‐eight patients had an isolated nodal recurrence (surveillance, 6%; CLND, 4%). In patients who received adjuvant treatment without undergoing prior CLND, all isolated nodal recurrences were resectable. On risk‐adjusted multivariable analyses, CLND was associated with improved isolated nodal RFS (hazard ratio [HR], 0.36; 95% CI, 0.15‐0.88), but not all‐site RFS (HR, 0.68; 95% CI, 0.45‐1.02). Adjuvant therapy improved all‐site RFS (HR, 0.52; 95% CI, 0.47‐0.57). DSS and DMFS did not differ by nodal management or adjuvant treatment.ConclusionsActive surveillance has been adopted for most SLN‐positive patients. At initial assessment, real‐world outcomes align with randomized trial findings, including in adjuvant therapy recipients.Lay Summary For patients with melanoma of the skin and microscopic spread to lymph nodes, monitoring with ultrasound is an alternative to surgically removing the remaining lymph nodes. The authors studied adoption and real‐world outcomes of ultrasound monitoring in over 1000 patients treated at 21 centers worldwide, finding that most patients now have ultrasounds instead of surgery. Although slightly more patients have cancer return in the lymph nodes with this strategy, typically, it can be removed with delayed surgery. Compared with up‐front surgery, ultrasound monitoring results in the same overall risk of melanoma coming back at any location or of dying from melanoma.
The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma
Chen, Zirong , Ni, Wei , Li, Jian‐Liang , Zhou, Xin , Li, Jennifer W. , Leon, Marino E. , Zolotukhin, Sergei, Lu, Jianrong , Griffin, James D. , Kaye, Frederic J. , Wu, Lizi , Lin, Shuibin , Sun, Yuping , Hurtado, Maria D. , Liu, Chen

Mayo Clinic

JCI Insight | April 7, 2021 | Volume: 6 | Issue: 7 | Pages: No page available

10.1172/jci.insight.139497 | PMID 33830080 Get It

No effective systemic treatment is available for patients with unresectable, recurrent, or metastatic mucoepidermoid carcinoma (MEC), the most common salivary gland malignancy. MEC is frequently associated with a t(11;19)(q14-21;p12-13) translocation that creates a CRTC1-MAML2 fusion gene. The CRTC1-MAML2 fusion exhibited transforming activity in vitro; however, whether it serves as an oncogenic driver for MEC establishment and maintenance in vivo remains unknown. Here, we show that doxycycline-induced CRTC1-MAML2 knockdown blocked the growth of established MEC xenografts, validating CRTC1-MAML2 as a therapeutic target. We further generated a conditional transgenic mouse model and observed that Cre-induced CRTC1-MAML2 expression caused 100% penetrant formation of salivary gland tumors resembling histological and molecular characteristics of human MEC. Molecular analysis of MEC tumors revealed altered p16-CDK4/6-RB pathway activity as a potential cooperating event in promoting CRTC1-MAML2–induced tumorigenesis. Cotargeting of aberrant p16-CDK4/6-RB signaling and CRTC1-MAML2 fusion–activated AREG/EGFR signaling with the respective CDK4/6 inhibitor Palbociclib and EGFR inhibitor Erlotinib produced enhanced antitumor responses in vitro and in vivo. Collectively, this study provides direct evidence for CRTC1-MAML2 as a key driver for MEC development and maintenance and identifies a potentially novel combination therapy with FDA-approved EGFR and CDK4/6 inhibitors as a potential viable strategy for patients with MEC.
Vascularized omental lymphatic transplant for upper extremity lymphedema: A systematic review
Jarvis, Nicholas R. , Forte, Antonio J. , Rebecca, Alanna M. , Teven, Chad M. , Torres, Ricardo A, Ávila, Francisco R. , Forte, Antonio Jorge , Teven, Chad M , Torres‐Guzman, Ricardo A.

Mayo Clinic

Cancer Reports | April 7, 2021 | Volume: 4 | Issue: 4 | Pages: No page available

10.1002/cnr2.1370 | PMID 33826249 Get It

AbstractBackgroundVascularized omental lymphatic transplant (VOLT) is an increasingly popular treatment of extremity lymphedema given its promising donor site. While the success of VOLT in the treatment of lymphedema has been reported previously, several questions remain.AimTo further elucidate appropriate use of VOLT in the treatment of lymphedema, specifically addressing patient selection, harvest technique, and operative methods.Methods and ResultsA systematic review of VOLT for upper extremity lymphedema was performed. Of 115 yield studies, seven were included for analysis based on inclusion and exclusion criteria. Included studies demonstrated significant reductions in extremity circumference/volume (average volume reduction, 22.7%‐39.5%) as well as subjective improvements using patient‐reported outcomes. Though studies are heterogenous and limited, when analyzed in aggregate, suggest the efficacy of VOLT in lymphedema treatment.ConclusionThis is the largest systematic review of VOLT to date. VOLT continues to show promise as a safe and efficacious surgical intervention for lymphedema in the upper extremity. Further studies are warranted to more definitively identify patients for whom this technique is appropriate as well as ideal harvest and inset technique.
Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States
Shah, Shrunjal, Gosain, Rohit , Groman, Adrienne , Gosain, Rahul , Hálfdánarson, Þorvarður R. , Mukherjee, Sarbajit , Halfdanarson, Thorvardur R , Dasari, Arvind

Mayo Clinic

Cancers | April 7, 2021 | Volume: 13 | Issue: 8 | Pages: 1753

10.3390/cancers13081753 | PMID 33916960 Get It

Background: The incidence and prevalence of neuroendocrine neoplasms (NENs) are rapidly rising. Epidemiologic trends have been reported for common NENs, but specific data for lung NENs are lacking. Methods: We conducted a retrospective analysis utilizing the Surveillance, Epidemiology, and End Results (SEER) database. Associated population data were utilized to report the annual age-adjusted incidence and overall survival (OS) trends. Trends for large-cell neuroendocrine carcinoma (LCNEC) and atypical carcinoid (AC) were reported from 2000–2015, while those for typical carcinoid (TC) and small cell lung cancer (SCLC) were reported from 1988–2015. Results: We examined a total of 124,969 lung NENs [103,890—SCLC; 3303—LCNEC; 8146—TC; 656—AC; 8974—Other]. The age-adjusted incidence rate revealed a decline in SCLC from 8.6 in 1988 to 5.3 in 2015 per 100,000; while other NENs showed an increase: TC increased from 0.57 in 1988 to 0.77 in 2015, AC increased from 0.17 in 2001 to 0.22 in 2015, and LCNEC increased from 0.16 in 2000 to 0.41 in 2015. The 5-year OS rate among SCLC, LCNEC, AC, and TC patients was 5%, 17%, 64%, and 84%, respectively. On multivariable analyses, OS and disease-specific survival (DSS) varied significantly by stage, sex, histological type, insurance type, marital status, and race, with a better survival noted in earlier stages, females, married, insured, Hispanic and other races, and urban population. Similarly, TC and AC had better survival compared to SCLC and LCNEC. Conclusion: The incidence of lung NENs is rising, possibly in part because of advanced radiological techniques. However, the incidence of SCLCs is waning, likely because of declining smoking habits. Such population-based studies are essential for resource allocation and to prioritize future research directions.
Faculty Opinions recommendation of Pneumatic dilation for persistent dysphagia after antireflux surgery, a multicentre single-blind randomised sham-controlled clinical trial.
Song, Louis M. Wong Kee

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 7, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.739378372.793583976 Get It

Application of the ACR Pancreatic Cyst Recommendations in Clinical Practice: Counterpoint—Ample Cost, Unknown Value
Hough, David M., Levy, Michael J.

Mayo Clinic

American Journal of Roentgenology | April 7, 2021 | Volume: 217 | Issue: 5 | Pages: 1055-1056

10.2214/ajr.21.25882 | PMID 33825499 Get It

Diagnosis and Treatment of Cardiac Amyloidosis. A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
García‐Pavía, Pablo , Adler, Yehuda , Arad, Michael , Basso, Cristina , Brucato, Antonio , Burazor, Ivana , Fontana, Marianna , González-López, Esther , Grogan, Martha , Heymans, Stéphane , Kindermann, Ingrid , Kristen, Arnt V. , Merlini, Giampaolo , Pantazis, Antonis, Pankuweit, Sabine , Rigopoulos, Angelos G. , Brucato, Antonio , Merlini, Giampaolo , Gillmore, Julian D , Garcia-Pavia, Pablo , Heymans, Stephane , Basso, Cristina , Rapezzi, Claudio , Caforio, Alida L.P. , Damy, Thibaud , Eriksson, Urs , Fontana, Marianna , Gillmore, Julian D. , Imazio, Massimo , Maurer, Matthew J. , Linhart, Aleš

Mayo Clinic

European Journal of Heart Failure | April 7, 2021 | Volume: 23 | Issue: 4 | Pages: 512-526

10.1002/ejhf.2140 | PMID 33826207 Get It

Abstract Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice.
The Need for Patient-centered Education Among Patients Newly Diagnosed With a Pituitary Tumor
Donegan, Diane , Gowan, Tayler , Gruber, Rachel, Cottingham, Ann H. , Flanagan, Mindy , Erickson, Dana , Imperiale, Thomas F.

Mayo Clinic

Journal of the Endocrine Society | April 7, 2021 | Volume: 5 | Issue: 6 | Pages: No page available

10.1210/jendso/bvab061 | PMID 34056501 Get It

Abstract Objectives Brain tumors, including pituitary adenomas (PA), cause anxiety and distress, with a high unmet need for information correlating with increased anxiety. Condition-specific education may alleviate anxiety. We explored patients’ experience around the diagnosis of a PA and piloted a patient education intervention to address peridiagnostic anxiety in adults diagnosed with PA. Methods Anxiety, patient satisfaction, patient knowledge, and need for information were measured prior to, immediately after, and 1 month following the appointment in this multimethods study. A phone interview to explore patient diagnostic and intervention experiences was analyzed using qualitative methods. Results A total of 17 patients participated in the study; 15 completed the interview. The baseline need for information was high. Disease-specific anxiety decreased, and patient knowledge and satisfaction increased significantly after the initial visit. Interview analysis identified 3 main themes: (1) the importance of communication; (2) the need for information; and (3) the impact of the diagnosis on patient experience. Conclusions For patients with newly diagnosed PA, the diagnostic experience was associated with high levels of anxiety. Patients expressed a need for information. Information delivery reduced anxiety and had a positive impact on patient satisfaction. Practice Implications The study findings suggest a need for a streamlined diagnostic process with readily accessible information.